Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 15009691

Quantifying recrystallization by electron backscatter diffraction.

H Jazaeri·F J Humphreys
View original source ↗Export metadata ↓

Abstract

The use of high-resolution electron backscatter diffraction in the scanning electron microscope to quantify the volume fraction of recrystallization and the recrystallization kinetics is discussed. Monitoring the changes of high-angle grain boundary (HAGB) content during annealing is shown to be a reliable method of determining the volume fraction of recrystallization during discontinuous recrystallization, where a large increase in the percentage of high-angle boundaries occurs during annealing. The results are shown to be consistent with the standard methods of studying recrystallization, such as quantitative metallography and hardness testing. Application of the method to a highly deformed material has shown that it can be used to identify the transition from discontinuous to continuous recrystallization during which there is no significant change in the percentage of HAGB during annealing.

Explore related subjects

AlloysCrystallizationMicroscopy, ElectronJournal ArticleResearch Support, Non-U.S. Gov't

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

H Jazaeri, F J Humphreys. 2004. Quantifying recrystallization by electron backscatter diffraction.. https://doi.org/10.1111/j.0022-2720.2004.01296.x

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2005

Zirconia to Ti-6Al-4V braze joint for implantable biomedical device.

A strong, hermetic, reliable, and biocompatible ceramic-to-metal seal is essential for many implantable medical devices. Yttria-stabilized tetragonal zirconia polycrystals (Y-TZPs) and a titanium alloy Ti-6Al-4V were selected as the ceramic and metal components of the seal because both materials have excellent mechanical properties and favorable biocompatibility. A brazing method using titanium nickel (TiNi)-clad braze filler material is presented to bond the components together forming a seal. Laboratory tests show that the ceramic-to-metal seal is hermetic, strong, and resistant to electrochemical corrosion. Twenty-eight microstimulators utilizing the ceramic-to-metal seals were implanted in seven sheep to stimulate the hypoglossal nerve. When the tissue was evaluated by gross inspection at necropsy and examined histologically by a pathologist, there were no signs of local hemorrhage, infection, or hypoglossal nerve tissue damage.

Alloys↗
PubMed2005

Mechanical properties of cast Ti-Hf alloys.

This study examined the mechanical properties of a series of Ti-Hf alloys. Titanium alloys with 10 to 40 mass % Hf were made with titanium and hafnium sponge in an argon-arc melting furnace. Specimens cast into magnesia-based investment molds were tested for yield strength, tensile strength, percentage elongation, and modulus of elasticity. Vickers microhardness was determined at 25 to 600 microm from the cast surface. X-ray diffractometry was also performed. Commercially pure Ti (CP Ti) and pure Ti prepared from titanium sponge were used as controls. The data (n = 5) were analyzed with a one-way ANOVA and the Student-Newman-Keuls test (alpha = 0.05). The diffraction peaks of all the metals matched those for alpha Ti; no beta phase peaks were found. Alloys with Hf > or = 25% had significantly (p < 0.05) higher yield and tensile strength compared to the CP Ti and pure Ti. There were no significant differences (p > 0.05) in elongation among all the Ti-Hf alloys and CP Ti, whereas the elongation of alloys with Hf > or = 30% was significantly (p < 0.05) lower than that of the pure Ti. The cast Ti-Hf alloys tested can be considered viable alternatives to CP Ti because they were stronger than CP Ti and had similar elongation.

Alloys↗
PubMed2005

Electrolytic deposition of calcium etidronate drug coating on titanium substrate.

Wear debris-induced osteolysis is the major cause of aseptic loosening and failure of hip implants. One of the promising therapeutic interventions to improve the longevity of hip implants is to administrate bisphosphonate drug to inhibit osteoclastic bone resorption. This study aimed at developing new techniques of directly combining bisphosphonate with implants to achieve local delivery and controlled release of the drug. Instead of using soluble sodium salt, we proposed to apply sparingly soluble calcium salt of bisphosphonate as a potential long-term antiosteolysis coating on hip implants. Calcium salt of etidronate, a member of the bisphosphonate family of potent osteoclast inhibitors, was used in this pilot study. By adopting the electrolytic deposition (ELD) technique, which was developed for ceramic coatings including calcium phosphates, we demonstrated that a thin layer of calcium bisphosphonate could be deposited onto titanium surface. The drug coating is amorphous as characterized with X-ray diffraction, and has globular morphology under the scanning electron microscope. Electrospray-ionization mass-spectrometry (ESI-MS) and Fourier-transformed infrared spectroscopy confirmed that the molecular structure of the etidronate (m/z 205, H3L-, the single dissociated form of parent etidronic acid, denoted as H4L) was preserved after the ELD process. In vitro release into a "physiological" buffer solution confirmed that the etidronate concentration was limited by its low solubility. The etidronate concentration was 8 x 10(-5) M at day 1 and kept relatively stable at approximately 6 x 10(-5) M from day 2 to day 8. The deposition mechanisms of the drug coating and its potential efficacy as an antiosteolytic release source were discussed.

Alloys↗